External Networks in the Drug Industry
Executive Summary
As they seek to create external networks to gain access to innovation, drug companies follow one of three models: the discovery stimulator, the idea acquirer, or the product acquirer. A variety of forces--from earning pressure to competition for research talent to the need to launch products globally--are all contributing to the complexity of managing in this new environment.